Meningioma Clinical Trials in Columbus, Ohio
8 recruitingColumbus, Ohio
Showing 1–8 of 8 trials
Recruiting
Phase 2
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
Intracranial MeningiomaRecurrent MeningiomaNF2 Gene Mutation
Alliance for Clinical Trials in Oncology124 enrolled780 locationsNCT02523014
Recruiting
Phase 1Phase 2
RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
Recurrent Meningioma
Joshua Palmer30 enrolled1 locationNCT07150806
Recruiting
Cognitive Status After Removal of Skull Base Meningioma
Cognitive ImpairmentCognitive DeclineMeningioma+4 more
Ohio State University50 enrolled1 locationNCT04635657
Recruiting
Phase 1Phase 2
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
ParagangliomaPheochromocytomaMeningioma+4 more
Perspective Therapeutics300 enrolled19 locationsNCT05636618
Recruiting
Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
Grade 2 MeningiomaIntracranial Meningioma
NRG Oncology163 enrolled214 locationsNCT03180268
Recruiting
Phase 1Phase 2
Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
MeningiomaRecurrent Diffuse Intrinsic Pontine GliomaHigh Grade Glioma+10 more
Nationwide Children's Hospital65 enrolled4 locationsNCT05278208
Recruiting
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
CholangiocarcinomaHepatocellular CarcinomaRenal Cell Carcinoma+5 more
Mohamed Abdel-Rahman500 enrolled1 locationNCT04792463
Recruiting
Long-Term Longitudinal QoL in Patients Undergoing EEA
ChondrosarcomaMeningiomaPituitary Tumor+5 more
Ohio State University400 enrolled1 locationNCT04087902